Coeptis Therapeutics Holdings (COEP) said Friday it will launch a 1-for-20 reserve stock split of its issued and outstanding common shares to meet Nasdaq's minimum bid price requirement for continued listing.
The company's shares will start trading on a post-split basis on Tuesday, the biopharmaceutical company said.